MX2010004309A - Moduladores de piperidinil y piperazinil de gamma-secretasa. - Google Patents
Moduladores de piperidinil y piperazinil de gamma-secretasa.Info
- Publication number
- MX2010004309A MX2010004309A MX2010004309A MX2010004309A MX2010004309A MX 2010004309 A MX2010004309 A MX 2010004309A MX 2010004309 A MX2010004309 A MX 2010004309A MX 2010004309 A MX2010004309 A MX 2010004309A MX 2010004309 A MX2010004309 A MX 2010004309A
- Authority
- MX
- Mexico
- Prior art keywords
- secretase
- piperazinyl
- piperidinyl
- modulators
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se relaciona con los compuestos de Fórmula (I) como se describe en la presente, en donde las definiciones de Het, R0, R1, R2, R3, R4, R5, R6, R7, R8 y R9 se proporcionan en la descripción. Los compuestos de fórmula (1) son útiles para el tratamiento de enfermedades asociadas con la actividad de ?-secretasa, que incluye la enfermedad de Alzheimer. (Ver fórmula I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98118907P | 2007-10-19 | 2007-10-19 | |
PCT/US2008/079905 WO2009052126A1 (en) | 2007-10-19 | 2008-10-15 | PIPERIDINYL AND PIPERAZINYL MODULATORS OF γ-SECRETASE |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010004309A true MX2010004309A (es) | 2010-05-03 |
Family
ID=40090456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010004309A MX2010004309A (es) | 2007-10-19 | 2008-10-15 | Moduladores de piperidinil y piperazinil de gamma-secretasa. |
Country Status (19)
Country | Link |
---|---|
US (1) | US8252935B2 (es) |
EP (1) | EP2212287B1 (es) |
JP (1) | JP5439381B2 (es) |
KR (1) | KR101569391B1 (es) |
CN (1) | CN101903347B (es) |
AT (1) | ATE543799T1 (es) |
AU (1) | AU2008312612B2 (es) |
BR (1) | BRPI0817433A2 (es) |
CA (1) | CA2702837A1 (es) |
CO (1) | CO6270359A2 (es) |
CR (1) | CR11447A (es) |
EA (1) | EA017119B1 (es) |
ES (1) | ES2378594T3 (es) |
IL (1) | IL205045A (es) |
MX (1) | MX2010004309A (es) |
NI (1) | NI201000064A (es) |
NZ (1) | NZ584716A (es) |
WO (1) | WO2009052126A1 (es) |
ZA (1) | ZA201003519B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101903335A (zh) | 2007-10-19 | 2010-12-01 | 詹森药业有限公司 | 连接有胺的γ-分泌酶调节剂 |
MX2010004309A (es) | 2007-10-19 | 2010-05-03 | Janssen Pharmaceutica Nv | Moduladores de piperidinil y piperazinil de gamma-secretasa. |
EP2215043B1 (en) | 2007-10-19 | 2013-03-06 | Janssen Pharmaceutica, N.V. | Carbon linked modulators of y-secretase |
US20120135997A1 (en) | 2009-07-17 | 2012-05-31 | Shionogi & Co., Ltd. | Pharmaceutical composition comprising a lactam or benzenesulfonamide compound |
US20120129189A1 (en) * | 2009-07-17 | 2012-05-24 | Chulan Kwon | Methods of Controlling Cell Proliferation |
JP5883794B2 (ja) * | 2009-11-05 | 2016-03-15 | フィブロスタチン ソシエダ リミターダFibrostatin,Sociedad Limitada | 擬似q2ペプチドを用いるgpbp抑制 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2212287A (en) * | 1938-09-13 | 1940-08-20 | William S Stateler | Milk bottle holder |
BE790287A (fr) * | 1971-10-28 | 1973-04-19 | Delalande Sa | Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique |
BE826017R (fr) | 1974-03-19 | 1975-08-26 | Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique | |
US4252951A (en) | 1979-10-09 | 1981-02-24 | Eli Lilly And Company | Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid |
US5391817A (en) | 1993-12-21 | 1995-02-21 | Bristol-Myers Squibb | Biaryl phospholipase A2 inhibitors |
US5877399A (en) | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
US5416187A (en) * | 1994-04-04 | 1995-05-16 | Eastman Chemical Company | Process for the preparation of phenol-functional polyester resins |
EP1284729A4 (en) | 2000-04-13 | 2007-12-19 | Mayo Foundation | REDUCTION AGENTS OF A (BETA) 42 |
DE10131899A1 (de) | 2001-07-04 | 2003-02-27 | Boehringer Ingelheim Pharma | In vitro-Screening-Assay für gamma-Secretase |
AR049377A1 (es) * | 2004-04-05 | 2006-07-26 | Schering Corp | Inhibidores de secretasa gamma |
WO2005110963A1 (en) * | 2004-05-19 | 2005-11-24 | Cellzome Ag | (biphenyl-3-yl)-carboxylic acids and derivatives thereof and their use in therapy |
WO2006004555A1 (en) | 2004-06-30 | 2006-01-12 | Paysetter Pte Ltd | System and method for facilitating transfer of physical money and/or credit |
EP1789404B1 (en) * | 2004-06-30 | 2010-03-24 | Schering Corporation | Substituted n-arylsulfonylheterocyclic amines as gamma-secretase inhibitors |
DE102004033876B4 (de) | 2004-07-13 | 2009-01-15 | Christoph Kaesbohrer | Dreidimensionales Struktursystem |
GB0416508D0 (en) | 2004-07-23 | 2004-08-25 | Merck Sharp & Dohme | Therapeutic agents |
EP1650183A1 (en) | 2004-10-21 | 2006-04-26 | Cellzome Ag | (Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy |
WO2006088705A1 (en) * | 2005-02-14 | 2006-08-24 | Wyeth | Terphenyl guanidines as [beta symbol] -secretase inhibitors |
DK1847524T3 (da) | 2006-04-21 | 2010-01-11 | Cellzome Ltd | Terphenylderivater til behandling af Alzheimers sygdom |
ES2328616T3 (es) | 2006-04-21 | 2009-11-16 | Cellzome Limited | Acidos bifenil carboxilicos sustituidos y sus derivados. |
CN101490001A (zh) * | 2006-06-09 | 2009-07-22 | Icos股份有限公司 | 用作dp-2拮抗剂的取代的苯乙酸 |
US7897643B2 (en) | 2007-10-17 | 2011-03-01 | Janssen Pharmaceutica N.V. | Biphenyl carboxylic acids and derivatives thereof |
CN101903335A (zh) | 2007-10-19 | 2010-12-01 | 詹森药业有限公司 | 连接有胺的γ-分泌酶调节剂 |
EP2215043B1 (en) | 2007-10-19 | 2013-03-06 | Janssen Pharmaceutica, N.V. | Carbon linked modulators of y-secretase |
MX2010004309A (es) | 2007-10-19 | 2010-05-03 | Janssen Pharmaceutica Nv | Moduladores de piperidinil y piperazinil de gamma-secretasa. |
CA2702835A1 (en) | 2007-10-19 | 2009-04-23 | Janssen Pharmaceutica N.V. | Amide linked modulators of .gamma.-secretase |
US20090306392A1 (en) | 2007-10-19 | 2009-12-10 | Chih Yung Ho | Gsm intermediates |
US7968725B2 (en) | 2008-07-22 | 2011-06-28 | Janssen Pharmaceutica N.V. | Pyridinyl modulators of γ-secretase |
-
2008
- 2008-10-15 MX MX2010004309A patent/MX2010004309A/es active IP Right Grant
- 2008-10-15 ES ES08839601T patent/ES2378594T3/es active Active
- 2008-10-15 CN CN200880121603XA patent/CN101903347B/zh not_active Expired - Fee Related
- 2008-10-15 US US12/251,521 patent/US8252935B2/en not_active Expired - Fee Related
- 2008-10-15 NZ NZ584716A patent/NZ584716A/en not_active IP Right Cessation
- 2008-10-15 JP JP2010530071A patent/JP5439381B2/ja not_active Expired - Fee Related
- 2008-10-15 KR KR1020107010877A patent/KR101569391B1/ko not_active IP Right Cessation
- 2008-10-15 EP EP08839601A patent/EP2212287B1/en active Active
- 2008-10-15 AU AU2008312612A patent/AU2008312612B2/en not_active Ceased
- 2008-10-15 WO PCT/US2008/079905 patent/WO2009052126A1/en active Application Filing
- 2008-10-15 AT AT08839601T patent/ATE543799T1/de active
- 2008-10-15 BR BRPI0817433-4A patent/BRPI0817433A2/pt not_active IP Right Cessation
- 2008-10-15 EA EA201070495A patent/EA017119B1/ru not_active IP Right Cessation
- 2008-10-15 CA CA2702837A patent/CA2702837A1/en not_active Abandoned
-
2010
- 2010-04-13 IL IL205045A patent/IL205045A/en not_active IP Right Cessation
- 2010-04-16 NI NI201000064A patent/NI201000064A/es unknown
- 2010-04-30 CO CO10051578A patent/CO6270359A2/es not_active Application Discontinuation
- 2010-05-18 ZA ZA2010/03519A patent/ZA201003519B/en unknown
- 2010-05-19 CR CR11447A patent/CR11447A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EA201070495A1 (ru) | 2010-10-29 |
BRPI0817433A2 (pt) | 2015-06-16 |
ES2378594T3 (es) | 2012-04-16 |
JP5439381B2 (ja) | 2014-03-12 |
AU2008312612A2 (en) | 2010-07-22 |
CO6270359A2 (es) | 2011-04-20 |
NI201000064A (es) | 2010-09-13 |
EA017119B1 (ru) | 2012-09-28 |
CN101903347A (zh) | 2010-12-01 |
US8252935B2 (en) | 2012-08-28 |
CR11447A (es) | 2011-01-14 |
CN101903347B (zh) | 2013-03-27 |
ES2378594T8 (es) | 2013-02-27 |
IL205045A (en) | 2015-08-31 |
NZ584716A (en) | 2011-12-22 |
AU2008312612B2 (en) | 2013-11-28 |
IL205045A0 (en) | 2010-11-30 |
ZA201003519B (en) | 2012-07-25 |
KR101569391B1 (ko) | 2015-11-16 |
CA2702837A1 (en) | 2009-04-23 |
US20090105275A1 (en) | 2009-04-23 |
EP2212287A1 (en) | 2010-08-04 |
KR20100083829A (ko) | 2010-07-22 |
AU2008312612A8 (en) | 2010-05-27 |
EP2212287B1 (en) | 2012-02-01 |
JP2011500700A (ja) | 2011-01-06 |
ATE543799T1 (de) | 2012-02-15 |
AU2008312612A1 (en) | 2009-04-23 |
WO2009052126A1 (en) | 2009-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX348422B (es) | Inhibidores de arginasa y sus aplicaciones terapeuticas. | |
MY155517A (en) | Heterocyclic derivatives | |
MX336381B (es) | Boronatos como inhibidores de arginasa. | |
TN2009000388A1 (en) | 3-imidazolyl-indoles for the treatment of proliferative diseases | |
EA201001647A1 (ru) | Производные бензофурана, бензотиофена, бензотиазола в качестве fxr модуляторов | |
UA98961C2 (uk) | Похідні піразинону та їх застосування у лікуванні легеневих захворювань | |
TN2011000259A1 (en) | Substituted pyrimidines for the treatment of diseases such as cancer | |
TW200736233A (en) | Cyclohexyl piperazinyl methanone derivatives | |
EA201100138A1 (ru) | 4-феноксиметилпиперидины в качестве модуляторов активности gpr119 | |
MX2009003645A (es) | Azaciclilaminas n-sustituidas como antagonistas de histamina-3. | |
PH12015501293B1 (en) | Imidazopyridazine derivatives as gabaa receptor modulators | |
JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
MX2010004309A (es) | Moduladores de piperidinil y piperazinil de gamma-secretasa. | |
ATE466854T1 (de) | 1h-indol-6-ylpiperazin-1-ylmethanonderivate zur verwendung als h3-rezeptormodulatoren | |
MY162440A (en) | 2,5-disubstituted arylsulfonamide ccr3 antagonists | |
GB0525069D0 (en) | Organic compounds | |
MX2010004308A (es) | Moduladores enlazados a amida gamma secretasa. | |
MX2010004310A (es) | Moduladores de gamma-secretasa con enlaces de carbono. | |
DE602008002598D1 (en) | Cyclohexylderivate | |
MX2010010000A (es) | Derivados de 2-trifluorometilnicotinamida como agentes para aumentar el colesterol de lipoproteinas de alta densidad. | |
MX2010004311A (es) | Productos intermedios de moduladores de gamma-secretasa. | |
MX2010004318A (es) | Moduladores de la gamma-secretasa con enlaces de amina. | |
MX2009009768A (es) | Derivados de quinolina, composiciones farmaceuticas que los comprenden y su uso en eltratamiento de enfermedades del sistema nervisos central y periferico. | |
UA107920C2 (en) | Substituted pyrimidine for the treatment of diseases such as cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |